Caseware UK (AP4) 2022.0.179 2022.0.179 2023-03-3155685908942023-03-312022-04-01falseThe principal activity of the LLP during the year was that of a pharmacy.1314truefalseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. OC374887 2022-04-01 2023-03-31 OC374887 2021-04-01 2022-03-31 OC374887 2023-03-31 OC374887 2022-03-31 OC374887 c:Buildings c:LongLeaseholdAssets 2022-04-01 2023-03-31 OC374887 c:Buildings c:LongLeaseholdAssets 2023-03-31 OC374887 c:Buildings c:LongLeaseholdAssets 2022-03-31 OC374887 c:PlantMachinery 2023-03-31 OC374887 c:PlantMachinery 2022-03-31 OC374887 c:PlantMachinery c:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 OC374887 c:FurnitureFittings 2022-04-01 2023-03-31 OC374887 c:ComputerEquipment 2022-04-01 2023-03-31 OC374887 c:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 OC374887 c:PatentsTrademarksLicencesConcessionsSimilar 2023-03-31 OC374887 c:PatentsTrademarksLicencesConcessionsSimilar 2022-03-31 OC374887 c:CurrentFinancialInstruments 2023-03-31 OC374887 c:CurrentFinancialInstruments 2022-03-31 OC374887 c:Non-currentFinancialInstruments 2023-03-31 OC374887 c:Non-currentFinancialInstruments 2022-03-31 OC374887 c:CurrentFinancialInstruments c:WithinOneYear 2023-03-31 OC374887 c:CurrentFinancialInstruments c:WithinOneYear 2022-03-31 OC374887 c:Non-currentFinancialInstruments c:AfterOneYear 2023-03-31 OC374887 c:Non-currentFinancialInstruments c:AfterOneYear 2022-03-31 OC374887 c:Non-currentFinancialInstruments c:BetweenOneTwoYears 2023-03-31 OC374887 c:Non-currentFinancialInstruments c:BetweenOneTwoYears 2022-03-31 OC374887 c:Non-currentFinancialInstruments c:BetweenTwoFiveYears 2023-03-31 OC374887 c:Non-currentFinancialInstruments c:BetweenTwoFiveYears 2022-03-31 OC374887 d:UnitedKingdom 2022-04-01 2023-03-31 OC374887 d:UnitedKingdom 2021-04-01 2022-03-31 OC374887 c:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2023-03-31 OC374887 c:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2022-03-31 OC374887 c:FinancialLiabilitiesFairValueThroughProfitOrLoss c:UnlistedNon-exchangeTraded 2023-03-31 OC374887 c:FinancialLiabilitiesFairValueThroughProfitOrLoss c:UnlistedNon-exchangeTraded 2022-03-31 OC374887 e:FRS102 2022-04-01 2023-03-31 OC374887 e:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 OC374887 e:FullAccounts 2022-04-01 2023-03-31 OC374887 e:LimitedLiabilityPartnershipLLP 2022-04-01 2023-03-31 OC374887 c:WithinOneYear 2023-03-31 OC374887 c:WithinOneYear 2022-03-31 OC374887 c:BetweenOneFiveYears 2023-03-31 OC374887 c:BetweenOneFiveYears 2022-03-31 OC374887 e:PartnerLLP1 2022-04-01 2023-03-31 OC374887 e:PartnerLLP2 2022-04-01 2023-03-31 OC374887 c:OtherCapitalInstrumentsClassifiedAsEquity 2023-03-31 OC374887 c:OtherCapitalInstrumentsClassifiedAsEquity 2022-03-31 OC374887 c:FurtherSpecificReserve2ComponentTotalEquity 2023-03-31 OC374887 c:FurtherSpecificReserve2ComponentTotalEquity 2022-03-31 OC374887 c:FurtherSpecificReserve3ComponentTotalEquity 2023-03-31 OC374887 c:FurtherSpecificReserve3ComponentTotalEquity 2022-03-31 OC374887 f:PoundSterling 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure

Registered number: OC374887









HASLEMERE HEALTHCARE LLP







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2023

 
HASLEMERE HEALTHCARE LLP
 

INFORMATION




Designated Members

Community Pharmacies (UK) Limited
Haslemere Medical LLP

LLP registered number

OC374887

Registered office

2 Peterwood WayCroydonSurreyCR0 4UQ


 
HASLEMERE HEALTHCARE LLP
 

CONTENTS



Page
Members' Report
1
Statement of Comprehensive Income
2
Statement of Financial Position
3 - 4
Reconciliation of Members' Interests
5 - 6
Notes to the Financial Statements
7 - 18


 
HASLEMERE HEALTHCARE LLP
 
  
MEMBERS' REPORT
FOR THE YEAR ENDED 31 MARCH 2023

The Members present their annual report together with the financial statements of Haslemere Healthcare LLP ("the LLP") for the year ended 31 March 2023
 

Principal activities
 
 
The principal activity of the LLP during the year was that of a pharmacy.
 
 
Designated Members
 
 
The Designated Members who held office during the year ended and up to the date of signature of the financial statements were as follows:
Community Pharmacies (UK) Limited
Haslemere Medical LLP
 

 
Members' capital and interests
 
 
Each Member's subscription to the capital of the LLP is determined in accordance with the terms of the LLP Agreement.
 
 
Details of changes in Members' capital in the year ended 31 March 2023 are set out in the Reconciliation of Members' Interests.
 
 
Members are remunerated from the profits of the LLP and are required to make their own provision for tax, pensions and other benefits. Profits are allocated and divided between Members after finalisation of the financial statements. Members may draw a proportion of their profit share monthly during the year in which it is made, with the balance of profits being distributed after the year end, subject to the cash requirements of the business.
 

This report was approved by the Members and signed on their behalf by: 






................................................
Community Pharmacies (UK) Limited 
Designated Member

Date: 20 November 2023
Page 1

 
HASLEMERE HEALTHCARE LLP
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2023

2023
2022
Note
£
£

  

Turnover
 4 
1,460,067
1,318,479

Cost of sales
  
(1,019,274)
(890,960)

Gross profit
  
 
440,793
 
427,519

Administrative expenses
  
(459,383)
(490,651)

Operating loss
  
 
(18,590)
 
(63,132)

Interest payable and expenses
  
(4,700)
(2,825)

Loss before tax
  
 
(23,290)
 
(65,957)

Loss for the year before members' remuneration and profit shares
  
 
(23,290)
 
(65,957)

Loss for the year before members' remuneration and profit shares
  
(23,290)
(65,957)

Members' remuneration charged as an expense
  
(32,395)
(24,937)

Loss for the financial year available for discretionary division among members
  
 
(55,685)
 
(90,894)

There was no other comprehensive income for 2023(2022:£NIL).

The notes on pages 7 to 18 form part of these financial statements.

Page 2

 
HASLEMERE HEALTHCARE LLP
REGISTERED NUMBER: OC374887

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2023

2023
2022
Note
£
£

Fixed assets
  

Intangible assets
 7 
-
-

Tangible assets
 8 
25,863
30,843

  
25,863
30,843

Current assets
  

Stocks
 9 
46,165
46,421

Debtors: amounts falling due within one year
 10 
163,122
135,348

Cash at bank and in hand
 11 
2,354
3,028

  
211,641
184,797

Creditors: amounts falling due within one year
 12 
(447,255)
(427,288)

Net current liabilities
  
 
 
(235,614)
 
 
(242,491)

Total assets less current liabilities
  
(209,751)
(211,648)

Creditors: amounts falling due after more than one year
 13 
(64,296)
(77,695)

  
(274,047)
(289,343)

  

Net liabilities
  
(274,047)
(289,343)

Page 3

 
HASLEMERE HEALTHCARE LLP
REGISTERED NUMBER: OC374887
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2023

2023
2022
Note
£
£

Represented by:
  

Loans and other debts due to members within one year
  

Amounts due in respect of profits
  
399
399

Other amounts
  
179,169
108,188

  
179,568
108,587

Members' other interests
  

Members' capital classified as equity
  
2
2

Other reserves

  

(453,617)
(397,932)

  
 
(453,615)
 
(397,930)

  
(274,047)
(289,343)


Total members' interests
  

Loans and other debts due to Members
  
179,568
108,587

Members' other interests
  
(453,615)
(397,930)

  
(274,047)
(289,343)


The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small LLPs regime.

The entity was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008.

The Members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008, with respect to accounting records and the preparation of financial statements.

The financial statements were approved and authorised for issue by the Members and were signed on their behalf by: 


................................................
Community Pharmacies (UK) Limited
Designated Member

Date: 20 November 2023

The notes on pages 7 to 18 form part of these financial statements.

Page 4

 
HASLEMERE HEALTHCARE LLP
 

RECONCILIATION OF MEMBERS' INTERESTS
FOR THE YEAR ENDED 31 MARCH 2023








EQUITY
Members' other interests
DEBT
Loans and other debts due to members less any amounts due from members in debtors
Total members' interests
Members' capital (classified as equity)
Other reserves
Total
Amounts due in respect of profits
Other amounts
Total
Total

£
£
£
£
£
£
£

Amounts due to/(from) Members 

399
159,717
160,116


Balance at 1 April 2021 

2
(307,038)
(307,036)
399
159,717
160,116
(146,920)

Loss for the year available for discretionary division among members
 
-
(90,894)
(90,894)
-
-
-
(90,894)

Members' remuneration charged as expense
-
-
-
-
24,937
24,937
24,937

Drawings
-
-
-
-
(24,937)
(24,937)
(24,937)

Amounts introduced by Members
-
-
-
-
4,471
4,471
4,471

Repayment of debt
 
-
-
-
-
(56,000)
(56,000)
(56,000)

Amounts due to Members
 



399
108,188
108,587


Balance at 31 March 2022
 
2
(397,932)
(397,930)
399
108,188
108,587
(289,343)

Loss for the year available for discretionary division among Members
 
-
(55,685)
(55,685)
-
-
-
(55,685)

Members' remuneration charged as expense
-
-
-
-
32,395
32,395
32,395

Drawings
-
-
-
-
(32,395)
(32,395)
(32,395)

Amounts introduced by Members
 
-
-
-
-
70,981
70,981
70,981
Page 5

 
HASLEMERE HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

RECONCILIATION OF MEMBERS' INTERESTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023


Amounts due to Members
 



399
179,169
179,568


Balance at 31 March 2023 
2
(453,617)
(453,615)
399
179,169
179,568
(274,047)

The notes on pages 7 to 18 form part of these financial statements.

There are no existing restrictions or limitations which impact the ability of the Members of the LLP to reduce the amount of Members' other interests.

Page 6

 
HASLEMERE HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

1.


General information

Haslemere Healthcare LLP ("the LLP") is a limited liability partnership incorporated in England and Wales. The registered office is 2 Peterwood Way, Croydon, Surrey, United Kingdom, CR0 4UQ.
The LLP's principal activities and nature of its operations are disclosed in the Members' Report.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006 and the requirements of the Statement of Recommended Practice "Accounting by Limited Liability Partnerships".

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the LLP's accounting policies (see note 3).

The financial statements are prepared in sterling, which is the functional currency of the limited liability partnership. Monetary amounts in these financial statements are rounded to the nearest £.

The following principal accounting policies have been applied:

 
2.2

Going concern

The financial statements have been prepared on a going concern basis which assumes the LLP will continue to be able to meet its financial obligations as they fall due.
The pharmacy continues to trade in line with expectations both financially and operationally. The Members believe the LLP has sufficient current and future cash reserves and facilities available for it to meet its liabilities including financing obligations.
The Members will continue to provide additional financial support to the business, if required, to ensure that it is able to meet its financial obligations as they fall due.

 
2.3

Turnover

Turnover is shown, net of Value Added Tax, for goods and services provided to customers.

Page 7

 
HASLEMERE HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

2.Accounting policies (continued)

  
2.4

Members' participation rights

Members' participation rights are the rights of a Member against the LLP that arise under the Members' agreement (for example, in respect of amounts subscribed or otherwise contributed, remuneration and profits).
Members' participation rights in the earnings or assets of the LLP are analysed between those that are, from the LLP's perspective, either a financial liability or equity, in accordance with section 22 of FRS 102. Members' participation rights, including amounts subscribed or otherwise contributed by members, for example Members' capital, are classed as liabilities unless the LLP has an unconditional right to refuse payment to Members, in which case they are classified as equity.
All amounts due to Members that are classified as liabilities are presented within 'Loans and other debts due to Members' and, where such an amount relates to current year profits, they are recognised within ‘Members' remuneration charged as an expense’ in arriving at the relevant year’s result. Unallocated amounts that are classified as equity are shown within ‘Members' other interests’. Amounts recoverable from Members are presented as debtors and shown as amounts due from Members within Members’ interests.
Where there exists an asset and liability component in respect of an individual Member’s participation rights, they are presented on a gross basis unless the LLP has both a legally enforceable right to set off the recognised amounts and it intends either to settle on a net basis or to settle and realise these amounts simultaneously, in which case they are presented net.
Whilst the Members’ agreement does not differentiate between profits and losses for profit sharing purposes, it does stipulate that the LLP cannot demand additional contributions from Members and as a result the LLP does not have an unconditional right to demand payment from Members for losses. Therefore, they are not recognised as a recoverable asset and so remain within equity as other reserves.
Other amounts applied to Members, for example remuneration paid under an employment contract and interest on capital balances, are treated in the same way as all other divisions of profits, as described above, according to whether the LLP has, in each case, an unconditional right to refuse payment. Amounts payable to Members under employment contracts and unavoidable interest on Members capital are charged to “Members remuneration charged as an expense” in the relevant year.

 
2.5

Operating leases: the LLP as lessee

Rentals paid under operating leases are charged to the Statement of Comprehensive Income on a straight-line basis over the lease term.

 
2.6

Finance costs

Finance costs are charged to the Statement of Comprehensive Income over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 8

 
HASLEMERE HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

2.Accounting policies (continued)

 
2.7

Borrowing costs

All borrowing costs are recognised in the Statement of Comprehensive Income in the year in which they are incurred.

 
2.8

Pensions

Defined contribution pension plan
The LLP operates a defined contribution pension plan for its employees. A defined contribution pension plan is a pension plan under which the LLP pays fixed contributions into a separate entity. Once the contributions have been paid the LLP has no further payment obligations.
The contributions are recognised as an expense in the Statement of Comprehensive Income when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the LLP in independently administered funds.

 
2.9

Intangible assets

Intangible assets comprise a licence to trade as a pharmacy. Intangible assets are stated at cost less
amortisation and are reviewed for impairment whenever there is an indication that the carrying value may be impaired.

 
2.10

Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Leasehold property
-
7%
straight-line
Fixtures and fittings
-
20%
straight-line
Computer equipment
-
33%
straight-line

The assets' residual values, useful lives and depreciation methods are reviewed and, if applicable, adjusted prospectively if there is an indication of a significant change since the last reporting date.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Comprehensive Income.

Page 9

 
HASLEMERE HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

2.Accounting policies (continued)

 
2.11

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amounts of stocks over their estimated selling price less costs to complete and sell is recognised as an impairment loss in the Statement of Comprehensive Income. Reversals of impairment losses are also recognised in the Statement of Comprehensive Income.

 
2.12

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.13

Cash and cash equivalents

Cash and cash equivalents include cash in hand and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities. 

 
2.14

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.15

Financial instruments

The LLP only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Comprehensive Income.
For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.
For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the LLP would receive for the asset if it were to be sold at the reporting date.
Financial assets and liabilities are offset and the net amount reported in the Statement of Financial Position when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Page 10

 
HASLEMERE HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

2.Accounting policies (continued)

  
2.16

Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the LLP is demonstrably committed to terminate the employment of an employee or to provide termination benefits.


3.


Judgements in applying accounting policies and key sources of estimation uncertainty

In the application of the LLP's accounting policies, which are described in note 2, the Members are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
There are no critical judgements and estimations that the Members have made in the process of applying the LLP's accounting policies that have the significant effect on the amounts recognised in the financial statements.


4.


Turnover

The whole of the turnover is attributable to be that of retail pharmacy.

Analysis of turnover by country of destination:

2023
2022
£
£

United Kingdom
1,460,067
1,318,479

1,460,067
1,318,479


Page 11

 
HASLEMERE HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

5.


Employees

The average monthly number of persons (including Members with contracts of employment) employed during the year was as follows:


        2023
        2022
            No.
            No.







Pharmacy staff
13
14


6.


Information in relation to Members

2023
2022
£
£




Remuneration paid under an employment contract
14,595
13,179

Mandatory interest payments
17,800
11,758

32,395
24,937




Page 12

 
HASLEMERE HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

7.


Intangible assets




Licence

£



Cost


At 1 April 2022
1



At 31 March 2023

1



Amortisation


At 1 April 2022
1



At 31 March 2023

1



Net book value



At 31 March 2023
-



At 31 March 2022
-



Page 13

 
HASLEMERE HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

8.


Tangible fixed assets





Leasehold property
Fixtures and fittings and Computer equipment
Total

£
£
£



Cost


At 1 April 2022
67,333
26,753
94,086



At 31 March 2023

67,333
26,753
94,086



Depreciation


At 1 April 2022
38,488
24,755
63,243


Charge for the year on owned assets
4,495
485
4,980



At 31 March 2023

42,983
25,240
68,223



Net book value



At 31 March 2023
24,350
1,513
25,863



At 31 March 2022
28,845
1,998
30,843


9.


Stocks

2023
2022
£
£

Finished goods and goods for resale
46,165
46,421

46,165
46,421


Stock recognised as an expense in cost of sales during the year was £1,019,274 (2022 - £890,960).

Page 14

 
HASLEMERE HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

10.


Debtors

2023
2022
£
£


Trade debtors
138,755
116,778

Other debtors
22,980
17,505

Prepayments and accrued income
1,387
1,065

163,122
135,348



11.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
2,354
3,028

Less: bank overdrafts (Note 12)
(55,270)
(51,062)

(52,916)
(48,034)



12.


Creditors: Amounts falling due within one year

2023
2022
£
£

Bank overdrafts
55,270
51,062

Bank loans (Note 13)
17,233
17,233

Trade creditors
238,905
182,298

Other taxation and social security
5,271
4,139

Other creditors
68,897
130,200

Accruals and deferred income
61,679
42,356

447,255
427,288


Bank loans and overdrafts for which security has been given amounted to £72,503 (2022 - £68,295).

Page 15

 
HASLEMERE HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

13.


Creditors: Amounts falling due after more than one year

2023
2022
£
£

Bank loans
64,296
77,695

64,296
77,695


The aggregate amount of creditors falling due after more than one year, for which security has been given amounted to £64,296 (2022 - £77,695).
The bank loan is repayable by equal monthly instalments. Interest will be charged at 2% per annum over the Base Rate. 
The following securities have been given:
(a) Debenture comprising fixed and floating charges over all the assets and undertaking of the LLP, both present and future,
(b) Guarantee in favour of the Bank from Day Lewis Plc guaranteeing all liabilities of the LLP limited to £75,000,
(c) Guarantee in favour of the Bank from Dr. Marcus Panchaud, Dr. Alex Higham, Dr Melanie Cant, Dr. Nolan Geeves and Dr. Phillip Ridsdill-Smith guaranteeing all liabilities of the LLP limited to £75,000.


14.


Loans and other debts due to Members

In the event of a winding up the amounts included in "Loans and other debts due to Members" will rank equally with unsecured creditors.

Page 16

 
HASLEMERE HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

15.


Loans


Analysis of the maturity of loans is given below:


2023
2022
£
£

Amounts falling due within one year

Bank loans
17,233
17,233


17,233
17,233

Amounts falling due 1-2 years

Bank loans
17,233
17,233


17,233
17,233

Amounts falling due 2-5 years

Bank loans
47,063
60,462


47,063
60,462


81,529
94,928



16.


Financial instruments

2023
2022
£
£

Financial assets


Financial assets measured at fair value
2,354
3,028


Financial liabilities


Financial liabilities measured at fair value
(136,799)
(145,990)


17.


Pension commitments

The LLP operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the LLP in an independently administered fund. The pension cost charge represents contributions payable by the LLP to the fund and amounted to £4,533 (2022 - £3,086). Contributions totalling £1,035 (2022 - £534) were payable to the fund at the Balance Sheet date and are included in creditors.

Page 17

 
HASLEMERE HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

18.


Commitments under operating leases

At 31 March 2023 the LLP had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2023
2022
£
£


Not later than 1 year
59,366
35,472

Later than 1 year and not later than 5 years
227,472
-

286,838
35,472


19.


Related party transactions

Community Pharmacies (UK) Limited is a designated Member.
During the year management charges payable to Community Pharmacies (UK) Limited amounted to £14,595 
(2022 - £13,179).
During the year expenses totalling £44,189 
(2022 - £40,614) were paid by Community Pharmacies (UK) Limited. As at 31 March 2023 the LLP owed £6,941 (2022 - £5,960) to Community Pharmacies (UK) Limited.
Included in loans and other debts due to Members is an amount of £83,614 
(2022 - £51,114) owed to Community Pharmacies (UK) Limited. Interest charged on the loan during the year amounts to £8,900 (2022 - ££6,136).
Haslemere Medical LLP is a designated Member.
Included in loans and other debts due to Members is an amount of £83,614 
(2022 - £51,114) owed to Haslemere Medical LLP. Interest charged on the loan during the year amounts to £8,900 (2022 - £5,622).
During the year the LLP made purchases totalling £490,942 
(2022 - £433,124) from Day Lewis Medical Limited, a fellow subsidiary of the parent company of Community Pharmacies (UK) Limited, Day Lewis Plc. As at 31 March 2023 the LLP owed £122,766 (2022 - £75,242) to Day Lewis Medical Limited.

Page 18